Cargando…
Ranolazine for Angina in Hypertrophic Cardiomyopathy
Ranolazine is an antianginal and works by inhibiting late-sodium current (I(NaL)). However, its use is limited mostly to patients with coronary artery disease. However, literature has shown its potential benefit in relieving angina in hypertrophic cardiomyopathy. Hereby, we discuss two cases where r...
Autores principales: | Amin, Akhtar, Kim, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925191/ https://www.ncbi.nlm.nih.gov/pubmed/29850265 http://dx.doi.org/10.1155/2018/5142572 |
Ejemplares similares
-
Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014) -
Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008) -
Emerging clinical role of ranolazine in the management of angina
por: Vadnais, David S, et al.
Publicado: (2010) -
Intestinal angina in a patient with hypertrophic obstructive cardiomyopathy: a case report
por: Hamaoka, Takuto, et al.
Publicado: (2016) -
Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
por: Aldakkak, Mohammed, et al.
Publicado: (2013)